Angiotensin II-dependent growth of vascular smooth muscle cells requires transactivation of the epidermal growth factor receptor via a cytosolic phospholipase A2-mediated release of arachidonic acid-Reference-Cited by-同舟云学术

Angiotensin II-dependent growth of vascular smooth muscle cells requires transactivation of the epidermal growth factor receptor via a cytosolic phospholipase A2-mediated release of arachidonic acid

Published:2010-06 Issue:1 Volume:498 Page:50-56
ISSN:0003-9861
Container-title:Archives of Biochemistry and Biophysics
language:en
Short-container-title:Archives of Biochemistry and Biophysics

Author:

Freeman Ernest J.,Sheakley Maria L.,Clements Robert J.

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference37 articles.

1. Angiotensin-(1-7) Inhibits Vascular Smooth Muscle Cell Growth

2. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.

3. Angiotensin II Induces c-fos mRNA in Aortic Smooth Muscle

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin II facilitates neointimal formation by increasing vascular smooth muscle cell migration: Involvement of APE/Ref-1-mediated overexpression of sphingosine-1-phosphate receptor 1;Toxicology and Applied Pharmacology;2018-05

2. Gene expression profiles and signaling mechanisms in α2B-adrenoceptor-evoked proliferation of vascular smooth muscle cells;BMC Systems Biology;2017-06-28

3. UCN enhances TGF-beta-mediated mitoinhibition of VSMCs via counteracting TGF-beta-induced cPLA2 expression and activation;The International Journal of Biochemistry & Cell Biology;2016-11

4. Regulation of the Cardiac Sodium/Bicarbonate Cotransporter by Angiotensin II: Potential Contribution to Structural, Ionic and Electrophysiological Myocardial Remodelling;Current Cardiology Reviews;2013-02-01

5. Mechanisms underlying altered extracellular nucleotide-induced contractions in mesenteric arteries from rats in later-stage type 2 diabetes: effect of ANG II type 1 receptor antagonism;American Journal of Physiology-Heart and Circulatory Physiology;2011-11